"In the end, every part of the health care ecosystem ...

... has to step up and participate in the question of affordability. And this includes calls for transparency in the pricing of pharma products, which will have very positive results and create downward pressure on a pricing strategy that heretofore has been about everything you can get away with. I think pharma companies will be called on like health plans, which is to disaggregate the components of pricing to be very transparent about that and be prepared to discuss the rationale behind pricing. I think that trend toward transparency and calls from the political arena will be crucial to opening up the cover of the black box."

— Karen Ignagni, former longtime head of America's Health Insurance Plans and now the CEO of Emblem Health, Inc., told AIS's Health Plan Week in an exclusive interview.